Previous work has indicated that the gene expression of CDX1 is abnormally down-regulated in colon cancer-derived cell lines [30, 31], and our finding suggests that this TP53 somatic mutation is partly responsible for dysregulation of CDX1’s expression in colon cancer. This evidence concerns the gene CDX1 and colonic neoplasm.